B 
15.21
0.00%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥297.7m
FY2019FY2025
Net income
CN¥63.8m
FY2019FY2025
Free cash flow
−CN¥33.6m
FY2019FY2025
Shareholders' equity
CN¥1.05bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | CN¥297.7m | CN¥221.9m | CN¥175.7m | CN¥145.4m | CN¥124.5m | CN¥78.4m | CN¥9.4m |
| Research and development | CN¥125.3m | CN¥85.9m | CN¥71.3m | CN¥30.9m | CN¥31.6m | CN¥7.0m | CN¥1.8m |
| Operating income | −CN¥18.2m | CN¥52.7m | CN¥49.1m | CN¥47.9m | CN¥44.7m | CN¥36.8m | CN¥415,229 |
| Net income | CN¥63.8m | CN¥53.7m | CN¥55.5m | CN¥50.3m | CN¥44.0m | CN¥56.8m | CN¥6.5m |
| Diluted earnings per share | 0.49 | 0.40 | 0.42 | 0.38 | 0.33 | 0.43 | 0.05 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.21bn | CN¥668.0m | CN¥600.8m | CN¥544.8m | CN¥368.0m | CN¥127.8m | CN¥67.9m |
| Cash and short-term investments | CN¥439.2m | CN¥215.4m | CN¥230.6m | CN¥251.6m | CN¥212.1m | CN¥48.9m | CN¥23.6m |
| Total liabilities | CN¥149.8m | CN¥110.3m | CN¥99.4m | CN¥97.9m | CN¥59.3m | CN¥46.4m | CN¥52.5m |
| Debt | CN¥51.0m | CN¥61.8m | CN¥40.5m | CN¥37.5m | CN¥5.6m | CN¥3.0m | — |
| Shareholders' equity | CN¥1.05bn | CN¥553.6m | CN¥498.7m | CN¥442.3m | CN¥301.4m | CN¥81.4m | CN¥15.5m |
| Shares outstanding | 131m | 133m | 133m | 133m | 133m | 133m | 133m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥98.2m | CN¥44.8m | CN¥50.5m | −CN¥6.4m | −CN¥2.1m | CN¥26.0m | CN¥27.5m |
| Capital spending | −CN¥131.8m | −CN¥43.6m | −CN¥69.4m | −CN¥49.2m | −CN¥12.9m | −CN¥2.3m | −CN¥13.3m |
| Free cash flow | −CN¥33.6m | CN¥1.1m | −CN¥18.9m | −CN¥55.6m | −CN¥15.0m | CN¥23.7m | CN¥14.2m |
Latest quarters
By quarter end
| Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥84.7m | CN¥196.4m | CN¥103.8m | CN¥169.5m | CN¥56.0m | CN¥150.7m | CN¥26.3m | CN¥159.5m |
| Operating income | −CN¥60.2m | −CN¥594,320 | −CN¥17.1m | CN¥46.0m | −CN¥18.8m | CN¥82.0m | −CN¥35.5m | CN¥71.7m |
| Net income | −CN¥55.2m | CN¥62.9m | CN¥1.5m | CN¥59.5m | −CN¥4.8m | CN¥64.0m | −CN¥12.0m | CN¥86.3m |
| Diluted earnings per share | -0.43 | 0.48 | 0.01 | 0.45 | -0.04 | 0.48 | -0.09 | 0.65 |
| Cash from operations | — | CN¥38.0m | CN¥61.0m | CN¥47.0m | CN¥1.0m | CN¥39.0m | CN¥13.0m | −CN¥3.0m |
| Capital spending | — | −CN¥28.0m | −CN¥106.0m | −CN¥31.0m | −CN¥12.0m | −CN¥36.0m | −CN¥36.0m | −CN¥37.0m |
| Free cash flow | — | CN¥10.0m | −CN¥45.0m | CN¥16.0m | −CN¥11.0m | CN¥3.0m | −CN¥23.0m | −CN¥40.0m |
| Total assets | CN¥1.29bn | CN¥1.21bn | CN¥1.13bn | CN¥668.0m | CN¥565.1m | CN¥699.7m | — | CN¥625.4m |
| Cash and short-term investments | CN¥405.1m | CN¥439.2m | CN¥620.0m | CN¥215.4m | CN¥201.3m | CN¥268.6m | — | CN¥293.1m |
| Debt | CN¥21.5m | CN¥79.5m | CN¥77.7m | CN¥62.3m | CN¥50.5m | CN¥44.7m | — | CN¥26.8m |
| Shareholders' equity | CN¥986.3m | CN¥1.05bn | CN¥1.13bn | CN¥553.6m | CN¥494.6m | CN¥580.8m | — | CN¥507.8m |
Financial ratios
Data as of 2 Nov 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | -6.1% | 26.2% | 29.7% | 34.6% | 36.9% | 73.9% |
| Net margin | 21.4% | 24.2% | 31.6% | 34.6% | 35.3% | 72.4% |
| Return on equity | 6.1% | 9.7% | 11.1% | 11.4% | 14.6% | 69.8% |
| Return on assets | 5.3% | 8.0% | 9.2% | 9.2% | 11.9% | 44.5% |
| Free cash flow yield | 4.0% | 2.1% | 2.3% | -0.3% | -0.1% | — |
| Revenue growth | 15.2% | 26.3% | 20.9% | 36.0% | 58.8% | 735.6% |
| Earnings growth | 2.1% | -3.3% | 10.2% | 33.3% | -22.6% | 772.8% |
| Current ratio | 9.28x | 7.57x | 7.85x | 5.41x | 6.60x | 2.19x |
| Debt to equity | 0.02x | 0.06x | 0.08x | 0.11x | 0.03x | 0.04x |
| Equity ratio | 86.9% | 82.9% | 83.0% | 81.2% | 81.9% | 63.7% |
| Interest coverage | -2.45x | 49.28x | 36.05x | 29.30x | 145.39x | 531.45x |
| R&D as a share of sales | 42.1% | 38.7% | 40.6% | 21.3% | 25.4% | 8.9% |
| Buybacks as a share of market value | 1.5% | 0.0% | 0.0% | 0.0% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 27.0% | 30.6% | — |
| Net income | 8.2% | 2.4% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 6.6% | 15.6% | 20.4% | — |
| Net margin | 22.6% | 26.6% | 31.1% | — |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | 24.2 |
| Price to sales | 5.2 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.